Triple Helix Science
Last Updated: September 2026 · Triple Helix Science Legal & Regulatory Affairs

Privacy Policy

Triple Helix Science ("THS", "we", "us", or "our") is dedicated to protecting the privacy, confidentiality, and security of patient, physician, sovereign partner, and clinical researcher data. This Privacy Policy outlines how we collect, handle, protect, and process scientific and personal information in accordance with HIPAA, GDPR, UAE Federal Decree-Law No. 45/2021 on Personal Data Protection, and applicable global biomedical data standards.

1. Scope of This Policy

This Privacy Policy applies to all data collected through the Triple Helix Science website, institutional consultation portals, physician referral gateways, clinical trial registry communications, and collaborative sovereign research dashboards.

  • Protected Health Information (PHI) transmitted for physician referral or clinical evaluation
  • Scientific collaborator, investigator, and institutional stakeholder credentials
  • Enterprise and sovereign government partnership inquiry communications
  • Technical session information, browser telemetry, and digital security access logs

2. Processing of Clinical & Translational Research Data

We handle clinical and translational data with the highest tier of confidentiality and regulatory rigor. Patient data received through institutional channels is subject to strict de-identification protocols before being utilized in research modeling.

  • All genomic sequence data and longitudinal medical records are pseudonymized and stored in compliance with local sovereignty frameworks.
  • We do not sell, rent, commercialize, or share identifiable patient or clinical records with third-party advertisers under any circumstances.
  • Research data sharing is restricted exclusively to accredited Institutional Review Boards (IRBs), independent ethics committees, and authorized clinical trial investigators.

3. Data Security & Sovereign Multi-Jurisdictional Architecture

Triple Helix Science employs defense-in-depth cybersecurity protocols, enterprise-grade encryption, and geographically sovereign data nodes to prevent unauthorized access, alteration, or disclosure of sensitive scientific records.

  • End-to-end encryption for all data in transit (TLS 1.3) and at rest (AES-256).
  • Geographically isolated databases respecting jurisdictional data residency across North America, the European Union, and the United Arab Emirates.
  • Zero-trust network architecture, multi-factor authentication, and annual third-party SOC 2 Type II compliance audits.

4. Individual Rights & Consent Management

Depending on your jurisdiction, you possess statutory rights concerning personal data held by Triple Helix Science, including the right to inspect, correct, or request deletion of contact and administrative records.

  • Right to request details of personal contact information maintained within our communications registers.
  • Right to withdraw consent for non-clinical correspondence and institutional updates at any time.
  • Clinical trial participants maintain rights governed by specific informed consent documentation and local clinical research statutes.

5. Regulatory Inquiries & Data Protection Contact

If you have questions regarding this Privacy Policy, sovereign data governance, or wish to exercise data subject rights, please contact our Global Data Protection Officer.

  • Global Data Protection Officer: privacy@triplehelixscience.com
  • Mailing Address: Triple Helix Science Legal & Regulatory Affairs, Global Headquarters
Notice: This policy is reviewed semi-annually to incorporate evolving standards in precision medicine, artificial intelligence in biotechnology, and sovereign healthcare regulatory requirements.